Aliskiren: Just a New Drug for Few Selected Patients or an Innovative Molecule Predestinated to Replace Arbs and Ace-Inhibitors?

Author： Novo Salvatore Fazio Giovanni Raccuglia Elena

Publisher： MDPI

E-ISSN： 1424-8247|2|3|118-124

ISSN： 1424-8247

Source： Pharmaceuticals, Vol.2, Iss.3, 2009-11, pp. : 118-124

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novo, S. et al. Aliskiren: Just a New Drug for Few Selected Patients or an Innovative Molecule Predestinated to Replace Arbs and Ace-Inhibitors? Pharmaceuticals 2009, 2, 118-124

By Novo Salvatore Fazio Giovanni Raccuglia Elena Mignano Antonino Novo Giuseppina

Pharmaceuticals, Vol. 4, Iss. 10, 2011-09 ,pp. : 1293-1294

MDPI

Access to resources Recommend Favorite

Targeted Secretion Inhibitors—Innovative Protein Therapeutics

By Foster Keith Chaddock John

Toxins, Vol. 2, Iss. 12, 2010-12 ,pp. : 2795-2815

MDPI

Access to resources Recommend Favorite

Angiotensin-I-Converting Enzyme (ACE) Inhibitors from Marine Resources: Prospects in the Pharmaceutical Industry

By Wijesekara Isuru Kim Se-Kwon

Marine Drugs, Vol. 8, Iss. 4, 2010-03 ,pp. : 1080-1093

MDPI

Access to resources Recommend Favorite

Suppression of Autoimmune Arthritis by Small Molecule Inhibitors of the JAK/STAT Pathway

By Malemud Charles J.

Pharmaceuticals, Vol. 3, Iss. 5, 2010-05 ,pp. : 1446-1455

MDPI

Access to resources Recommend Favorite

In Search of Small Molecule Inhibitors Targeting the Flexible CK2 Subunit Interface

By Bestgen Benoît Belaid-Choucair Zakia Lomberget Thierry Le Borgne Marc Filhol Odile Cochet Claude

Pharmaceuticals, Vol. 10, Iss. 1, 2017-02 ,pp. : 16-16

MDPI

Access to resources Recommend Favorite